Revolution Medicines (RVMD) Other Gross PP&E Adjustments (2019 - 2026)

Revolution Medicines' Other Gross PP&E Adjustments history runs 8 years deep, the most recent figure standing at -$67.7 million for Q1 2026.

• On a quarterly basis, Other Gross PP&E Adjustments fell 3.83% year-over-year to -$67.7 million in Q1 2026; TTM through Mar 2026 was -$67.7 million, a 3.83% decrease from a year earlier, with the FY2025 full-year figure at -$70.4 million, up 1.46% from the prior year.
• Other Gross PP&E Adjustments improved to -$67.7 million in Q1 2026 per RVMD's latest filing, from -$70.4 million in the prior quarter.
• Across five years, Other Gross PP&E Adjustments topped out at $9.2 million in Q1 2023 and bottomed at -$74.5 million in Q3 2025.
• The 5-year median for Other Gross PP&E Adjustments is -$33.6 million (2024), against an average of -$39.1 million.
• Across the five-year window, Other Gross PP&E Adjustments jumped 127.11% in 2023 and tumbled 465.16% in 2024, its largest moves.
• Year by year, Other Gross PP&E Adjustments stood at -$21.9 million in 2022, then sank by 66.86% to -$36.6 million in 2023, then sank by 95.2% to -$71.4 million in 2024, then increased by 1.46% to -$70.4 million in 2025, then increased by 3.75% to -$67.7 million in 2026.
• Per Business Quant, the three latest RVMD Other Gross PP&E Adjustments figures stand at -$67.7 million (Q1 2026), -$70.4 million (Q4 2025), and -$74.5 million (Q3 2025).